Movatterモバイル変換


[0]ホーム

URL:


GB0602046D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0602046D0
GB0602046D0GBGB0602046.5AGB0602046AGB0602046D0GB 0602046 D0GB0602046 D0GB 0602046D0GB 0602046 AGB0602046 AGB 0602046AGB 0602046 D0GB0602046 D0GB 0602046D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0602046.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham CorpfiledCriticalSmithKline Beecham Corp
Priority to GBGB0602046.5ApriorityCriticalpatent/GB0602046D0/en
Publication of GB0602046D0publicationCriticalpatent/GB0602046D0/en
Priority to PCT/EP2007/050823prioritypatent/WO2007088148A1/en
Ceasedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

GBGB0602046.5A2006-02-012006-02-01CompoundsCeasedGB0602046D0 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
GBGB0602046.5AGB0602046D0 (en)2006-02-012006-02-01Compounds
PCT/EP2007/050823WO2007088148A1 (en)2006-02-012007-01-29Derivatives of thiophene carboxilic acid as antiviral agent

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB0602046.5AGB0602046D0 (en)2006-02-012006-02-01Compounds

Publications (1)

Publication NumberPublication Date
GB0602046D0true GB0602046D0 (en)2006-03-15

Family

ID=36100863

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GBGB0602046.5ACeasedGB0602046D0 (en)2006-02-012006-02-01Compounds

Country Status (2)

CountryLink
GB (1)GB0602046D0 (en)
WO (1)WO2007088148A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JO3598B1 (en)2006-10-102020-07-05Infinity Discovery IncBoronic acids and esters as inhibitors of fatty acid amide hydrolase
WO2008043791A2 (en)*2006-10-132008-04-17Smithkline Beecham CorporationThiophene derivatives for treating hepatitis c
US7964580B2 (en)2007-03-302011-06-21Pharmasset, Inc.Nucleoside phosphoramidate prodrugs
AU2008248116A1 (en)2007-05-042008-11-13Vertex Pharmaceuticals IncorporatedCombination therapy for the treatment of HCV infection
AR072249A1 (en)2008-04-092010-08-18Infinity Pharmaceuticals Inc INHIBITORS OF AMIDA HYDROLASS ACID FAT. APPLICATIONS. METHODS
US8173621B2 (en)2008-06-112012-05-08Gilead Pharmasset LlcNucleoside cyclicphosphates
KR101529062B1 (en)*2008-09-052015-06-16가부시키가이샤 한도오따이 에네루기 켄큐쇼Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same
NZ617066A (en)2008-12-232015-02-27Gilead Pharmasset LlcNucleoside analogs
PA8855601A1 (en)2008-12-232010-07-27 NUCLEOSID FORFORMIDATES
WO2010075554A1 (en)2008-12-232010-07-01Pharmasset, Inc.Synthesis of purine nucleosides
WO2010118155A1 (en)2009-04-072010-10-14Infinity Pharmaceuticals, Inc.Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en)2009-04-072010-10-14Infinity Pharmaceuticals, Inc.Inhibitors of fatty acid amide hydrolase
TWI583692B (en)2009-05-202017-05-21基利法瑪席特有限責任公司Nucleoside phosphoramidates
US8618076B2 (en)2009-05-202013-12-31Gilead Pharmasset LlcNucleoside phosphoramidates
US8993604B2 (en)2009-06-302015-03-31Siga Technologies, Inc.Treatment and prevention of dengue virus infections
MX336687B (en)*2009-06-302016-01-28Siga Technologies IncTreatment and prevention of dengue virus infections.
SG182475A1 (en)2010-01-152012-08-30Gilead Sciences IncInhibitors of flaviviridae viruses
CA2788587C (en)2010-02-032020-03-10Infinity Pharmaceuticals, Inc.Fatty acid amide hydrolase inhibitors
UY33312A (en)2010-03-312011-10-31Pharmasset Inc PURINE NUCLEOSIDE PHOSPHORAMIDATE
CL2011000718A1 (en)2010-03-312012-04-09Gilead Pharmasset Llc Process for the preparation of enantiomeric phosphorus compounds.
US8563530B2 (en)2010-03-312013-10-22Gilead Pharmassel LLCPurine nucleoside phosphoramidate
WO2012075140A1 (en)2010-11-302012-06-07Pharmasset, Inc.Compounds
US8889159B2 (en)2011-11-292014-11-18Gilead Pharmasset LlcCompositions and methods for treating hepatitis C virus
SG11201600919UA (en)2013-08-272016-03-30Gilead Pharmasset LlcCombination formulation of two antiviral compounds
CN110143940B (en)*2019-05-072022-12-30中国科学技术大学Method for preparing 2, 5-furan diformyl chloride from 2, 5-furan diformyl aldehyde

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE10359791A1 (en)*2003-12-192005-07-21Bayer Healthcare Ag Substituted thiophenes

Also Published As

Publication numberPublication date
WO2007088148A1 (en)2007-08-09

Similar Documents

PublicationPublication DateTitle
GB0602424D0 (en)Compounds
GB0602046D0 (en)Compounds
GB0605786D0 (en)Compounds
GB0606876D0 (en)Compounds
EP1984379A4 (en)Anti-arenaviral compounds
GB0607175D0 (en)Compounds
GB0605784D0 (en)Compounds
GB0605785D0 (en)Compounds
EP2082022A4 (en)Compounds
GB0606913D0 (en)Compounds
EP2004174A4 (en)Naphthalenedione compounds
GB0602042D0 (en)Compounds
EP1973905A4 (en)Compounds
AP2009004767A0 (en)Cubstituted azolin-2-yl-amino compounds
GB0602560D0 (en)Compounds
GB0602412D0 (en)Compounds
GB0600427D0 (en)Compounds
GB0603129D0 (en)Compounds
GB0605539D0 (en)Compounds
GB0602558D0 (en)Compounds
GB0602559D0 (en)Compounds
GB0602454D0 (en)Compounds
GB0602853D0 (en)Compounds
GB0602856D0 (en)Compounds
GB0602451D0 (en)Compounds

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)

[8]ページ先頭

©2009-2025 Movatter.jp